Utility of Lung Ultrasound in the Estimation of Extravascular Lung Water in Pediatric Population
1 other identifier
observational
25
1 country
1
Brief Summary
Increased extravascular lung water (EVLW) may increase mortality and morbidity in cardiopulmonary pathology. Many factors can cause increased extravascular lung water and pulmonary edema after cardiac surgery. This includes left ventricular failure, acute mitral regurgitation; systemic inflammatory response post-cardiopulmonary bypass, left to right shunts, transfusion associated acute lung injury, acute respiratory distress syndrome(ARDS) and sepsis. The clinical assessment of lung water ranges from auscultation to radiological methods to invasive measurements like dye dilution or thermodilution studies. Lung ultrasonography is the newest modality for noninvasive assessment of extravascular lung water. Lung ultrasound has been validated against auscultation, chest X-rays, CT chest as well as the bedside gold standard, transpulmonary thermodilution in adults. Critically ill children are more susceptible to complications and worsened outcomes from increased EVLW. Lung ultrasound correlates with clinical and radiological endpoints, but has not been validated against invasive objective measures like transpulmonary thermodilution. Evaluation of transpulmonary thermodilution setups in the pediatric population has shown different normal values and cutoffs compared to adults, possibly due to differential rates growth and development. It is aimed to investigate the correlation of Lung ultrasound based indices of extravascular lung water to invasive measures, assess optimum cutoffs to appropriate clinical endpoints and evaluate their sensitivity and specificity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2019
CompletedFirst Submitted
Initial submission to the registry
June 2, 2020
CompletedFirst Posted
Study publicly available on registry
June 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2020
CompletedSeptember 14, 2020
September 1, 2020
1 year
June 2, 2020
September 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
correlation of lung USG B-line score with PICCO derived EVLW / EVLWI in pediatric cardiac surgical patients.
Till extubation or second post-operative day.
cutoffs for lung USG B-line score to Predict abnormal EVLWI values.
Till extubation or second post-operative day.
Secondary Outcomes (1)
trending ability of lung USG B-line score to predict PICCO derived EVLW / EVLWI in pediatric cardiac surgical patients.
Till extubation or second post-operative day.
Study Arms (1)
Study population
Children under 12 years of age, Undergoing elective cardiac surgery for cyanotic or acyanotic congenital heart disease, Aristotle score ≤9, Giving prior written informed consent.
Interventions
Lung ultrasonography by 8 Quadrant protocol of Volpicelli et al. Transpulmonary thermodilution for extravascular lung water measurement
Eligibility Criteria
Children with cyanotic or acyanotic heart undergoing elective cardiac surgery.
You may qualify if:
- aged under 12 years,
- undergoing elective cardiac surgery for cyanotic or acyanotic congenital heart disease,
- Aristotle score ≤9,
- with prior written informed consent
You may not qualify if:
- Neonates,
- Children with any chest wall deformity,
- children with known lung disease, active infection,
- those weighing less than 3.5 kg.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Postgraduate Institute of Medical Education & Research
Chandigarh, 160012, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bhupesh Kumar, DM
Post Graduate Institute of Medical Education and Research, Chandigarh
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Fellow, Cardiac Anaesthesia
Study Record Dates
First Submitted
June 2, 2020
First Posted
June 5, 2020
Study Start
August 10, 2019
Primary Completion
August 15, 2020
Study Completion
August 30, 2020
Last Updated
September 14, 2020
Record last verified: 2020-09